VEPSELTA Trademark

Trademark Overview


On Friday, July 21, 2023, a trademark application was filed for VEPSELTA with the United States Patent and Trademark Office. The USPTO has given the VEPSELTA trademark a serial number of 98095381. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, July 15, 2025. This trademark is owned by Glaxo Group Limited. The VEPSELTA trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders
vepselta

General Information


Serial Number98095381
Word MarkVEPSELTA
Filing DateFriday, July 21, 2023
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, July 15, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 7, 2024

Trademark Statements


Goods and ServicesVaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, August 21, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB

Trademark Events


Event DateEvent Description
Monday, August 21, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 25, 2023NEW APPLICATION ENTERED
Monday, March 25, 2024ASSIGNED TO EXAMINER
Wednesday, April 17, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, April 1, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 7, 2024PUBLISHED FOR OPPOSITION
Tuesday, May 7, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 2, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 12, 2024AMENDMENT AFTER NOA NOT ENTERED
Tuesday, November 12, 2024NOTICE OF ALLOWANCE CANCELLED
Friday, June 27, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, June 30, 2025ABANDONMENT - NO USE STATEMENT FILED
Monday, June 30, 2025ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Wednesday, July 9, 2025REINSTATEMENT GRANTED - INADVERTENTLY ABANDONED
Tuesday, July 15, 2025TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, July 15, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, July 15, 20251(B) BASIS DELETED; PROCEED TO REGISTRATION
Tuesday, November 12, 2024TEAS DELETE 1(B) BASIS RECEIVED